Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

SINOPHARM Aktie

 >SINOPHARM Aktienkurs 
2.267 EUR    -2.7%    (TradegateBSX)
Ask: 2.302 EUR / 1500 Stück
Bid: 2.257 EUR / 1500 Stück
Tagesumsatz: 964 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
SINOPHARM Aktie über LYNX handeln
>SINOPHARM Performance
1 Woche: -1,9%
1 Monat: +0,2%
3 Monate: +4,8%
6 Monate: +11,0%
1 Jahr: -1,9%
laufendes Jahr: +7,7%
>SINOPHARM Aktie
Name:  SINOPHARM GRP CO. H YC 1
Land:  China
Sektor:  Handel
ISIN/ Wkn:  CNE100000FN7 / A0N99U
Symbol/ Ticker:  X2S (Frankfurt)
Kürzel:  FRA:X2S, ETR:X2S, X2S:GR
Index:  -
Webseite:  http://ir.sinopharmgroup...
Profil:  Sinopharm Group Co., Ltd. is a prominent healthcare conglomerate that plays a vital role in China's pharmaceutical industry. Specializing in the manufacturing, distribution, and retail of healthcare p..
>Volltext..
Marktkapitalisierung:  7178.98 Mio. EUR
Unternehmenswert:  22495.74 Mio. EUR
Umsatz:  68407.26 Mio. EUR
EBITDA:  2515.1 Mio. EUR
Nettogewinn:  809.1 Mio. EUR
Gewinn je Aktie:  0.26 EUR
Schulden:  15351.22 Mio. EUR
Liquide Mittel:  5685.28 Mio. EUR
Operativer Cashflow:  392.17 Mio. EUR
Bargeldquote:  0.17
Umsatzwachstum:  -11.98%
Gewinnwachstum:  -28.96%
Dividende je Aktie:  0.08 EUR
Dividendenrendite:  3.54%
Dividendenschätzung:  3.54%
Div. Historie:  16.06.25 - 0.081615165€
17.06.24 - 0.105580635€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  SINOPHARM
Letzte Datenerhebung:  22.03.26
>SINOPHARM Kennzahlen
Aktien/ Unternehmen:
Aktien: 1341.81 Mio. St.
Frei handelbar: 99.77%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 108217
Umsatz/Mitarb.: 0.65 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: -5.49%
Bewertung:
KGV: 9.01
KGV lG: 7.77
KUV: 0.11
KBV: 0.75
PEG-Ratio: -
EV/EBITDA: 8.94
Rentabilität:
Bruttomarge: 7.09%
Gewinnmarge: 1.18%
Operative Marge: 2.87%
Managementeffizenz:
Gesamtkaprendite: 1.59%
Eigenkaprendite: 8.7%
>SINOPHARM Peer Group
Handel, Apotheken
 
23.03.26 - 02:15
Results: SINOPHARM Annual NP Grows 1.5% to RMB7.155B; Final Div. RMB0.69 (AAStocks)
 
SINOPHARM (01099.HK) has announced its annual results for the period ended December 2025.The company's turnover declined by 1.6% YoY to RMB575.168 billion, while net profit amounted to RMB7.155 billion, up 1.5% YoY, with EPS at RMB2.29.A final dividend of RMB0.69 was declared, compared to the dividend of RMB0.68 in the same ......
19.03.26 - 14:48
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials (PR Newswire)
 
BELLEVUE, Wash., March 19, 2026 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a healthcare-focused holding company advancing innovative medical technologies, today announced that its subsidiary, Woori IO Co., Ltd. ("Woori IO"), has entered into a mutual non-disclosure agreement......
19.03.26 - 14:06
OSR Holdings, Inc.: Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities (Accesswire)
 
BELLEVUE, WA / ACCESS Newswire / March 19, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a healthcare-focused holding company advancing innovative medical technologies, today announced that its subsidia......
25.02.26 - 09:15
Full-day Takeaway: HSI Closes at 26,765, Up 175 pts; HSTI Closes at 5,260, Down 10 pts; HAIDILAO Up over 6%; HSBC HOLDINGS, TINGYI, SINOPHARM, TIME INTERCON, WANGUO GOLD GP Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 175 pts or 0.7% to 26,765. HSTI dropped 10 pts or 0.2% to 5,260. HSCEI gained 26 pts or 0.3% to 9,034. Market turnover reached $236.77 billion.Active Heavyweights:PING AN (02318.HK) closed at $71.15, up 1.9%MEITUAN (03690.HK) closed at $82.7, up 1.6%TENCENT (00700.HK) closed at $522.5, up 0.5%XIAOMI (01810.HK)......
25.02.26 - 05:30
Midday Takeaway: HSI Closes Midday at 26,789, Up 199 pts; HSTI Closes Midday at 5,288, Up 17 pts; HAIDILAO Up over 5%; LI NING, SINOPHARM, CHINA RES MIXC, HENGAN INT'L, MTR CORPORATION Hit New Highs (AAStocks)
 
At midday close, HSI rose 199 pts or 0.8% to 26,789. HSTI rose 17 pts or 0.3% to 5,288. HSCEI gained 81 pts or 0.9% to 9,088.Active Heavyweights:MEITUAN (03690.HK) closed at $83.3, up 2.3%PING AN (02318.HK) closed at $71.4, up 2.3%TENCENT (00700.HK) closed at $526.5, up 1.3%BABA (09988.HK) closed at $149.3, up 0.9%XIAOMI (01810.......
24.02.26 - 09:15
Full-day Takeaway: HSI Down 491 pts; HSTI Down 114 pts; MEITUAN Down over 4%; PING AN Down over 4%; TENCENT Down over 3%; WH GROUP, HENDERSON LAND, CKI HOLDINGS, MTR CORPORATION, SINOPHARM Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI dropped 491 pts or 1.8% to 26,590. HSTI dropped 114 pts or 2.1% to 5,270. HSCEI fell 189 pts or 2.1% to 9,007. Market turnover reached $250.99 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $81.4, down 4.2%PING AN (02318.HK) closed at $69.8, down 4.1%TENCENT (00700.HK) closed at $520, down 3.3%BABA (09988......
24.02.26 - 05:30
Midday Takeaway: HSI Down 523 pts; HSTI Down 127 pts; MEITUAN Down over 4%; PING AN Down over 4%; TENCENT Down over 3%; WH GROUP, HENDERSON LAND, CKI HOLDINGS, SINOPHARM, KB LAMINATES Hit New Highs (AAStocks)
 
At midday close, HSI dropped 523 pts or 1.9% to 26,558. HSTI dropped 127 pts or 2.4% to 5,258. HSCEI fell 190 pts or 2.1% to 9,007.Active Heavyweights:MEITUAN (03690.HK) closed at $80.95, down 4.8%PING AN (02318.HK) closed at $69.75, down 4.2%TENCENT (00700.HK) closed at $519.5, down 3.4%BABA (09988.HK) closed at $147.7, down 3%......
23.02.26 - 09:15
Full-day Takeaway: HSI Up 668 pts; HSTI Up 173 pts; MEITUAN Up over 5%; BABA Up over 3%; XIAOMI Up over 3%; LI NING, TECHTRONIC IND, SINOPHARM, SHK PPT, HENDERSON LAND Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 668 pts or 2.5% to 27,081. HSTI rose 173 pts or 3.3% to 5,385. HSCEI gained 237 pts or 2.7% to 9,197. Market turnover reached $172.96 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $85, up 5.3%BABA (09988.HK) closed at $152.2, up 3.5%XIAOMI (01810.HK) closed at $36.56, up 3.4%PING AN (02318.HK) close......
26.01.26 - 03:00
SINOPHARM's Subsidiary Sinopharm Accord Envisions Max. 90% Surge in Last Yr's NP (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
11.11.25 - 04:30
Research: HSBC Research Cuts TPs for SH PHARMA/ SINOPHARM; CN Drug Industry Lacks ST Catalysts (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
27.10.25 - 04:30
Research: CLSA Sees CN Biopharma Stock Pullback as Compelling Buy Opportunity, Favors CSPC PHARMA/ SINOPHARM (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.25 - 09:00
SINOPHARM Leaps 4%+; M Stanley Bets on Shr Price Rise in Next 30 Days (AAStocks)
 
SINOPHARM (01099.HK) reached a peak of HKD19.64 this morning. It last traded at HKD19.52, up 4.3%, with a trading volume of 8.426 million shares, involving HKD163 million.Morgan Stanley has published a strategic research report saying that SINOPHARM's stock price will have a 70-80% chance of rising within the next 30 days. A......
22.10.25 - 05:45
Research: M Stanley Estimates SINOPHARM to Rise in Next 30 Days (AAStocks)
 
Morgan Stanley wrote in its research report that SINOPHARM (01099.HK) will have a 70-80% chance of rising in the next 30 days. It gave the company an Overweight rating and a target price of HKD22.5.The report highlighted that two subsidiaries of SINOPHARM had announced their 3Q25 results, which showed a positive QoQ turnaround a......
26.08.25 - 06:15
Research: BofAS Adds SINOPHARM TP to $23, Reaffirms Rating at Buy (AAStocks)
 
SINOPHARM (01099.HK)'s 1H25 total revenue fell 2.9% YoY to RMB286 billion, BofA Securities issued a research report saying. Gross profit margin decreased from 7.4% in the same period last year to 7.1%, while net profit attributable to shareholders dropped by 6.4% YoY to RMB3.5 billion. In 2Q25, total revenue increased by -2.......
26.08.25 - 05:30
Research: Citi Drops SINOPHARM TP to $22.7, Rating Buy (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
25.08.25 - 03:15
Results: SINOPHARM Interim NP RMB3.466B, Down 6.4%; Nil Div. (AAStocks)
 
SINOPHARM (01099.HK) announced its interim results for the six months ending June 30, 2025, reporting revenue of RMB286.043 billion, down 2.9% YoY. Net profit fell 6.4% YoY to RMB3.466 billion, with EPS of RMB1.11. No dividend was declared.~AASTOCKS Financial NewsWebsite: www.aastocks.com...
23.07.25 - 11:45
Global Dental Leaders to Convene in Shanghai for FDI World Dental Congress 2025 (PR Newswire)
 
SHANGHAI, July 23, 2025 /PRNewswire/ -- The FDI World Dental Congress (WDC), one of the world's premier events for the oral health profession, will take place in Shanghai, China, from September 9–12, 2025, co-hosted by Chinese Stomatological Association and Reed Sinopharm Exhibitions.......
15.07.25 - 05:45
Research: M Stanley Cuts SINOPHARM TP to $22.5, Rating Overweight (AAStocks)
 
Morgan Stanley released a research report lowering its 2025-2030 earnings forecasts for SINOPHARM (01099.HK) by 1-6%, due to lower sales forecasts for the medical device and drug distribution segments. The broker cut its target price from $23 to $22.5, with rating at Overweight. ~AASTOCKS Financial NewsWebsite: www.aastocks.com...
15.06.25 - 21:18
XFRA: DIVIDEND/INTEREST INFORMATION - 16.06.2025 - EQUBF_01 (XETRA)
 
Das Instrument X2S CNE100000FN7 SINOPHARM GRP CO. H YC 1 EQUITY wird ex Dividende/Zinsen gehandelt am 16.06.2025 The instrument X2S CNE100000FN7 SINOPHARM GRP CO. H YC 1 EQUITY has its ex-dividend/interest day on 16.06.2025...
12.06.25 - 23:42
XFRA: DIVIDEND/INTEREST INFORMATION - 16.06.2025 - EQUBF_01 (XETRA)
 
Das Instrument X2S CNE100000FN7 SINOPHARM GRP CO. H YC 1 EQUITY wird cum Dividende/Zinsen gehandelt am 13.06.2025 und ex Dividende/Zinsen am 16.06.2025 The instrument X2S CNE100000FN7 SINOPHARM GRP CO. H YC 1 EQUITY has its pre-dividend/interest day on 13.06.2025 and its ex-dividend/interest day on 16.06.2025...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Quod cito fit, cito perit - Was schnell entsteht, auch schnell vergeht. - Nomen Nescio
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!